402 related articles for article (PubMed ID: 30394665)
1. LncRNA GAS6-AS2 promotes bladder cancer proliferation and metastasis via GAS6-AS2/miR-298/CDK9 axis.
Rui X; Wang L; Pan H; Gu T; Shao S; Leng J
J Cell Mol Med; 2019 Feb; 23(2):865-876. PubMed ID: 30394665
[TBL] [Abstract][Full Text] [Related]
2. LncRNA GAS6-AS2 promotes non-small-cell lung cancer cell proliferation via regulating miR-144-3p/ MAPK6 axis.
Hou G; Yang J; Tang J; He Y
Cell Cycle; 2021 Jan; 20(2):179-193. PubMed ID: 33459113
[TBL] [Abstract][Full Text] [Related]
3. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of long noncoding RNA GAS6-AS2 promotes proliferation and inhibits apoptosis of melanoma cells via upregulating GAS6 expression.
Wen L; Zheng Y; Wen X; Zhang Y; Zeng W
IUBMB Life; 2019 Oct; 71(10):1503-1514. PubMed ID: 31162889
[TBL] [Abstract][Full Text] [Related]
5. USF1-mediated upregulation of lncRNA GAS6-AS2 facilitates osteosarcoma progression through miR-934/BCAT1 axis.
Wei G; Zhang T; Li Z; Yu N; Xue X; Zhou D; Chen Y; Zhang L; Yao X; Ji G
Aging (Albany NY); 2020 Apr; 12(7):6172-6190. PubMed ID: 32269179
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA GAS6-AS2 sponges microRNA-493, thereby enhancing the malignant characteristics of breast cancer cells via upregulation of FUT4.
Li W; Jin X; Zhao Y; Dai J; Cai Y
Pathol Res Pract; 2020 Feb; 216(2):152772. PubMed ID: 31839366
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
[TBL] [Abstract][Full Text] [Related]
9. Platycodin D (PD) regulates LncRNA-XIST/miR-335 axis to slow down bladder cancer progression in vitro and in vivo.
Chen D; Chen T; Guo Y; Wang C; Dong L; Lu C
Exp Cell Res; 2020 Nov; 396(1):112281. PubMed ID: 32919956
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG3 promotes bladder cancer proliferation and metastasis through miR-515-5p/GINS2 axis.
Dai G; Huang C; Yang J; Jin L; Fu K; Yuan F; Zhu J; Xue B
J Cell Mol Med; 2020 Aug; 24(16):9231-9243. PubMed ID: 32596993
[TBL] [Abstract][Full Text] [Related]
11. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
12. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA (lncRNA) HOXD-AS2 promotes glioblastoma cell proliferation, migration and invasion by regulating the miR-3681-5p/MALT1 signaling pathway.
Zhong X; Cai Y
Bioengineered; 2021 Dec; 12(2):9113-9127. PubMed ID: 34802389
[TBL] [Abstract][Full Text] [Related]
14. LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the MiR-195/ARL2 Signaling Pathway.
Li HJ; Sun XM; Li ZK; Yin QW; Pang H; Pan JJ; Li X; Chen W
Cell Physiol Biochem; 2017; 43(6):2548-2561. PubMed ID: 29130995
[TBL] [Abstract][Full Text] [Related]
15. Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p/Smad3 axis.
Kang W; Wang Q; Dai Y; Wang H; Wang M; Wang J; Zhang D; Sun P; Qi T; Jin X; Cui Z
Cell Death Dis; 2020 Dec; 11(12):1038. PubMed ID: 33288752
[TBL] [Abstract][Full Text] [Related]
16. Long Noncoding RNA HOXA-AS2 Promotes Papillary Thyroid Cancer Progression by Regulating miR-520c-3p/S100A4 Pathway.
Xia F; Chen Y; Jiang B; Du X; Peng Y; Wang W; Huang W; Feng T; Li X
Cell Physiol Biochem; 2018; 50(5):1659-1672. PubMed ID: 30384358
[TBL] [Abstract][Full Text] [Related]
17. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215.
Kong X; Duan Y; Sang Y; Li Y; Zhang H; Liang Y; Liu Y; Zhang N; Yang Q
J Cell Physiol; 2019 Jun; 234(6):9105-9117. PubMed ID: 30362551
[TBL] [Abstract][Full Text] [Related]
18. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.
Rui X; Xu Y; Jiang X; Ye W; Huang Y; Jiang J
Cell Death Dis; 2018 Dec; 9(12):1175. PubMed ID: 30518760
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression.
Zhang P; Dong Q; Zhu H; Li S; Shi L; Chen X
Gene; 2019 May; 696():1-9. PubMed ID: 30735718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
